Mylan Signs Strategic Alliance Disney Parks and Resorts


On November 7, 2014, Mylan Inc. announced a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening (severe) allergic reaction. The agreement includes updated maps in Disney’s domestic theme parks and on its cruise ships, as well as updated signage in the parks that highlights locations with EpiPen (epinephrine) and EpiPen Jr. Auto-Injectors.


Here is just an example of how the new park maps will look (Disney's Hollywood Studios map):


The companies also plan to introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions. Here is the official press-release:

PITTSBURGH, Nov. 7, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening (severe) allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® (epinephrine) and EpiPen Jr® (epinephrine) Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.

EpiPen® locations will roll out at Disney parks and on cruise ships beginning in late 2014. In addition to emergency medical services (EMS), nurses trained to administer EpiPen Auto-Injectors are available during First Aid station operating hours to assist guests experiencing a severe allergic reaction. To help guests identify EpiPen locations, Disney's guide maps will now include an EpiPen Auto-Injector symbol and new signage at First Aid stations.

"Mylan's mission is to provide the world's 7 billion people access to high quality medicine and set new standards in health care. In support of this mission, we are committed to enhancing access to EpiPen Auto-Injectors and to increasing awareness of anaphylaxis. Like life, severe allergic reactions are unpredictable, so people need to be prepared," said Mylan CEO Heather Bresch. "We are very proud to be working with Disney, which already has a strong reputation for meeting the needs of people managing severe allergies, and believe we can further raise awareness of anaphylaxis through this collaboration and our joint commitment to education."

Anaphylaxis is unpredictable, and can progress quickly and without warning. Clinical guidelines state that epinephrine is the first-line treatment when anaphylaxis occurs, making access critical. For those with a known risk, it is important to be prepared with an anaphylaxis action plan that includes 1) avoiding known allergens, 2) recognizing the signs and symptoms of anaphylaxis, 3) having immediate access to two epinephrine auto-injectors, such as EpiPen Auto-Injector, and 4) seeking immediate emergency medical care should anaphylaxis occur.

"For our guests who live with severe allergies every day, identifying EpiPen locations is an additional tool they'll have for their anaphylaxis management plan," said Dr. Pamela Hymel, chief medical officer for Walt Disney Parks and Resorts. "This new strategic alliance will help raise awareness of EpiPen locations so that our Guests with severe allergies may have the best possible experience at our parks and on our cruise ships."

Families managing known severe allergies are encouraged to follow their individual anaphylaxis action plans and carry their epinephrine auto-injectors with them at all times.

Click on this link to learn more about Mylan Inc. and to read more information about this partnership.

Comments

  1. That's all fine and good.
    But stop there. Don't let the next step be the wholesale removal of any food somebody just might be allergic towards.

    People with allergies must take personal responsiblity for their conditions and not continually try to foist them onto others.

    Some will call me a 'hater' some will say I'm insensitive - and that will prove my point. They'll say "no one is suggesting". But look around and you'll find many people ARE suggesting.

    Many people with allergies do take care of themselves, but they are not the vocal ones who constantly push to ban one thing or another, who seek some perfectly sterile environment at the expense of others.

    Just recall what happened with the new Dumbo walkways were revealed, with peanut shell impressions. Fake peanut shell impressions/patterns in concrete were said to cause children to spasm and cry in terror. There was an actual effort to get Disney to redo that concrete, to eliminate the "offensive" shell patterns.

    Highlighting locations of medical services and equipment is fine - but again, stop there.

    ReplyDelete
  2. I agree it should stop there. It's true that many people need to carry epipens in case its needed. My nephew included. However, I think it's a win win marketing plan for the drug company that makes epipen and Disney. They can promote the product and I'm sure Disney was paid to do this. They market it to make it seem as important as AED and FirstAid. Also, I thought you have to have a prescribed epipen by a doctor for your specific allergy. I guess they made one we ALL can buy. I see right through this.

    ReplyDelete
  3. We have always carried our own epi pens to the Disney parks and still plan to do so. I'm not sure how to take the news. It seems that now people with severe allergies may leave their own pens at home thinking they can use Disney's supply and save some money (since they do cost a pretty penny).
    I think Disney does a great job with allergies and does not need to NOT have certain foods. We always eat at the Plaza Restaurant and my daughter is treated like a princess.
    I don't think there is any need to go any further. As everyone said, people with allergies need to take responsibility for their own health. We do and it works out fine.

    ReplyDelete

Post a Comment